Search results
Jump to navigation
Jump to search
- ...th [[sitagliptin]] and [[vildagliptin]] it has shown a superior profile. [[Xanthines]] are believed to have higher [[potency (pharmacology)|potency]], longer-la ...32 KB (4,417 words) - 10:31, 12 March 2024
- ...th [[sitagliptin]] and [[vildagliptin]] it has shown a superior profile. [[Xanthines]] are believed to have higher [[potency (pharmacology)|potency]], longer-la ...33 KB (4,561 words) - 10:30, 12 March 2024
- ...agliptin/ja|シタグリプチン]]や[[vildagliptin/ja|ビルダグリプチン]]と比較すると、優れたプロフィールを示している。[[xanthines/ja|キサンチン]]は[[potency (pharmacology)/ja|効力]]が高く、阻害作用がより長く持続し、[[glucose toler ...41 KB (1,558 words) - 17:16, 12 March 2024
- ...in susceptibility to toxic compounds (ex. canines' inability to metabolize xanthines such as caffeine). Some drugs undergo metabolism in both species via differ ...38 KB (5,401 words) - 20:37, 15 March 2024
- ...in susceptibility to toxic compounds (ex. canines' inability to metabolize xanthines such as caffeine). Some drugs undergo metabolism in both species via differ ...39 KB (5,513 words) - 20:35, 15 March 2024
- 52 KB (6,923 words) - 17:09, 5 November 2023
- 54 KB (7,245 words) - 17:08, 5 November 2023